THC Stock Analysis: Buy, Sell, or Hold?
THC - Tenet Healthcare Corporation New
$178.75
6.18 (3.58%)
▲
5d:
+2.34%
30d:
-4.62%
90d:
-10.78%
BUY
HIGH Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Jul 28, 2026
Smart Money Accumulation
None View Scanner →
Strength: 7.6/10
Get Alerted When THC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: THC appears deeply undervalued. Market expects -4.4% annual earnings decline despite 88% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: THC appears deeply undervalued. Market expects -4.4% annual earnings decline despite 88% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$55.67
Based on -20.8% avg growth
INTRINSIC VALUE TODAY
$34.57
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: THC is currently trading at $178.75, which is considered fair relative to its 30-day fair value range of $166.49 to $189.60. From a valuation perspective, the stock is trading at a discount (Forward PE: 10.1) compared to its historical average (11.5). Remarkably, the market is currently pricing in an annual earnings decline of 4.4% over the next few years. This pessimistic expectation contrasts with the company's recent 87.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, THC is in a downtrend. The price is approaching resistance at $182.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: THC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $243.62 (+36.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, THC is in a downtrend. The price is approaching resistance at $182.69. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: THC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $243.62 (+36.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$166.49 -
$189.60
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 36.3% below Wall St target ($243.62)
Trading Range Analysis
30-Day Trading Range
$166.49 -
$189.60
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$157.58
Resistance Level
$182.69
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.08
Wall Street Target
$243.62
(+36.3%)
Revenue Growth (YoY)
2.8%
Earnings Growth (YoY)
87.6%
Profit Margin
7.9%
Valuation Discount vs History
-4.4% cheaper
PE vs Historical
10.1 vs 11.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.4%
(market-implied from PE analysis)
1-Year Target
$170.89
(-4%)
2-Year Target
$163.37
(-9%)
3-Year Target
$156.18
(-13%)
3-Yr Target (if PE normalizes)
(PE: 10→12)
$178.11
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -45.7%)
$380.81
(+113%)
Base:
(SPY PE: 10.1, Growth: -45.7%)
$176.31
(-1%)
Bear:
(PE: 8.6, Growth: -45.7%)
$149.87
(-16%)
📈
Valuation based on Current Earnings
Trailing PE: 8.98 | Current EPS (TTM): $19.22
Bull Case
$175.07
(-2%)
Analyst growth -7.8%, PE expands to 9.9
Base Case
$159.16
(-11%)
Market implied -7.8%, PE stable at 9.0
Bear Case
$117.35
(-34%)
Severe decline -20.0%, PE contracts to 7.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 10.1 to 11.5
Stabilization Target:
$203.85
(+14.0%)
PE Expansion Potential:
+14.0%
Share & Embed Analysis
Last updated: June 23, 2026 7:48 AM ET
Data refreshes hourly during market hours. Next update: 8:48 AM
Data refreshes hourly during market hours. Next update: 8:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is THC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Paola M Arbour
SELL
6500 shares
2026-03-11
Thomas W Arnst
SELL
8000 shares
2026-03-09
R. Scott Ramsey
SELL
8017 shares
2026-03-02
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$504 | 60 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 53 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 54 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 58 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 62 BUY |
Advanced THC Option Strategies
Professional options setups generated by AI based on today's THC price and gamma walls.
